Usman Shareef

Usman Shareef

Auto-generated profile, based on publicly available information

Usman Shareef

Department of Pharmaceutical Chemistry, Shifa College of Pharmaceutical Sciences, Shifa Tameer-e-Millat University

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2024 in Saudi Pharmaceutical Journal
Verified
Journal Article
Open access
USUsman Shareef
Usman Shareef
AAAisha Altaf
Aisha Altaf
MAMadiha Ahmed
Madiha Ahmed
NANosheen Akhtar
Nosheen Akhtar
MAMohammed S. Almuhayawi
Mohammed S. Almuhayawi
MNMohammed K. Nagshabandi
Mohammed K. Nagshabandi
To fully evaluate and define the new drug molecule for its pharmacological characteristics and toxicity profile, pre-clinical and clinical studies are conducted as part of the drug research and development process. The average time required for all drug development processes to finish various regulatory evaluations ranges from 11.4 to 13.5 years, and the expense of drug development is rising quickly. The development in the discovery of newer novel treatments is, however, largely due to the growing need for new medications. Methods to identify Hits and discovery of lead compounds along with pre-clinical studies have advanced, and one example is the introduction of computer-aided drug design (CADD), which has greatly shortened the time needed for the drug to go through the drug discovery phases. The pharmaceutical industry will hopefully be able to address the present and future issues and will continue to produce novel molecular entities (NMEs) to satisfy the expanding unmet medical requirements of the patients as the success rate of the drug development processes is increasing. Several heterocyclic moieties have been developed and tested against many targets and proved to be very effective. In-depth discussion of the drug design approaches of newly found drugs from 2020 to 2022, including their pharmacokinetic and pharmacodynamic profiles and in-vitro and in-vivo assessments, is the main goal of this review. Considering the many stages these drugs are going through in their clinical trials, this investigation is especially pertinent. It should be noted that synthetic strategies are not discussed in this review; instead, they will be in a future publication.

1 January 2023 in International Journal of Nanomedicine
Verified
Journal Article
Open access
PDF file
FNFAIZA NASEER
FAIZA NASEER
TATahir Ahmad
Tahir Ahmad
KKKousain Kousar
Kousain Kousar
SKSalik Javed Kakar
Salik Javed Kakar
RGRabia Gul
Rabia Gul
USUsman Shareef
Usman Shareef
Background: Oncolytic viruses are reported as dynamite against cancer treatment nowadays. Methodology: In the present work, a live attenuated oral measles vaccine (OMV) strain was used to formulate a polymeric surface-functionalized ligand-based nanoformulation (NF). OMV (half dose: not less than 500 TCID units; 0.25 mL) was encapsulated in thiolated chitosan and outermost coating with hyaluronic acid by ionic gelation method characterizing parameters was performed. Results and Discussion: CD44 high expression was confirmed in prostatic adenocarcinoma (PRAD) by GEPIA which extracted data of normal and cancer tissue from GTEx and TCGA. Bioinformatics tools confirmed the viral hemagglutinin capsid protein interaction with human Caspase-I, NLRP3, and TNF-α and viral fusion protein interaction with COX-II and Caspase-I after successful delivery of MV encapsulated in NFs due to high affinity of hyaluronic acid with CD44 on the surface of prostate cancer cells. Particle size = 275.6 mm, PDI = 0.372, and ± 11.5 zeta potential were shown by zeta analysis, while the thiolated group in NFs was confirmed by FTIR and Raman analysis. SEM and XRD showed a spherical smooth surface and crystalline nature, respectively, while TEM confirmed virus encapsulation within nanoparticles, which makes it very useful in targeted virus delivery systems. The virus was released from NFs in a sustained but continuous release pattern till 48 h. The encapsulated virus titer was calculated as 2.34× 107 TCID50/mL units, which showed syncytia formation on post-day infection 7. Multiplicities of infection 0.1, 0.5, 1, 3, 5, 10, 15, and 20 of HA-coated OMV-loaded NFs as compared to MV vaccine on PC3 was inoculated with IC50 of 5.1 and 3.52, respectively, and growth inhibition was seen after 72 h via MTT assay which showed apoptotic cancer cell death. Conclusion: Active targeted, efficacious, and sustained delivery of formulated oncolytic MV is a potent moiety in cancer treatment at lower doses with safe potential for normal prostate cells. Graphical Abstract:

10 May 2025 in Journal of Molecular Graphics and Modelling
Verified
Journal Article
Closed access
USUsman Shareef
Usman Shareef
MZMuhammad Kazim Zargaham
Muhammad Kazim Zargaham
AIAhsan Ibrahim
Ahsan Ibrahim
AAAisha Altaf
Aisha Altaf
RBRohail Bhatti
Rohail Bhatti

23 September 2026 in Critical Reviews in Analytical Chemistry
Verified
Journal Article
Closed access
SPShanza Poswal
Shanza Poswal
BNBushra Naureen
Bushra Naureen
USUsman Shareef
Usman Shareef
MAMehmood Asghar
Mehmood Asghar
ASAziza Sarwar
Aziza Sarwar
MIMahnoor Ilyas
Mahnoor Ilyas
Spectroscopic methods offer vital information on the molecular makeup, interactions, and structure of biological tissues by examining the relationship between matter and electromagnetic radiation. Conventional diagnostic procedures frequently have limitations, and early diagnosis of cancer is critical for improving patient outcomes. The purpose of this review article is to investigate the possible uses of several spectroscopic methods in the diagnosis of cancer, with an emphasis on breast cancer, cervical cancer, colorectal cancer, brain tumors, ovarian cancer, abdominal cancer, prostate cancer, lung cancer, ovarian cancer and esophageal cancer. An extensive overview of spectroscopic methods, such as nuclear magnetic resonance (NMR), mass spectrometry, infrared spectroscopy, and Raman spectroscopy, are explored for applications in the diagnosis of cervical, colorectal, gastric, breast and prostate malignancies. Spectroscopic methods have several benefits, including high sensitivity for identifying cancer biomarkers, noninvasiveness, and real-time findings. These techniques are becoming more and more useful for diagnosing breast cancer since they make it easier to grade tumors, classify malignancies early, and determine certain biomarkers. For these approaches to be used in clinical settings, assay development, automation, and collaborative study development are crucial. Although there are some difficulties, continuous developments in spectroscopy can hold the potential to revolutionize cancer detection and enhance patient care.